Vimarsana
Biggest News Aggregation in the World

Page 4 - Compuscript Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compuscript Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compuscript Ltd Today - Breaking & Trending Today

Assessing post-PCI optical flow ratio for improved cardiac risk management - Vimarsana News

Assessing post-PCI optical flow ratio for improved cardiac risk management

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The goal of this study was to examine the prognostic performance of optical flow ratio (OFR) among patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).

Clinical insights into hypertension following unilateral adrenalectomy - Vimarsana News

Clinical insights into hypertension following unilateral adrenalectomy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Patients who undergo adrenalectomy for unilateral primary aldosteronism (PA) may still develop post-surgery hypertension; however, the clinical characteristics and etiology of patients developing recurrent hypertension after adrenalectomy are unclear.

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis - Vimarsana News

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Announcing a new article publication for Zoonoses journal. Shanghai and Hong Kong, China, experienced an outbreak of COVID-19 in early 2022.

Understanding the interplay between gut microbiota and vascular dysfunction - Vimarsana News

Understanding the interplay between gut microbiota and vascular dysfunction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Vascular diseases, including atherosclerosis, aneurysms, and vascular calcification, are a leading cause of morbidity and mortality worldwide.

CPAP therapy may not reduce heart risks in sleep apnea patients with coronary artery disease - Vimarsana News

CPAP therapy may not reduce heart risks in sleep apnea patients with coronary artery disease

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obstructive sleep apnea (OSA) is highly common in patients with coronary artery disease (CAD) and it is a strong predictor of subsequent cardiovascular events.